Patent Assignment
Reel/Frame 062881/0090
Release of Security Interest
Recorded: 2023-03-03
Pages: 10
Assignor
HERCULES CAPITAL, INC.
Executed: 2023-02-07
Assignees
NABRIVA THERAPEUTICS GMBH
LEBERSTRASSE 20, 110 VIENNA, AUSTRIA
ZAVANTE THERAPEUTICS, INC.
12670 HIGH BLUFF DRIVE, SAN DIEGO, CALIFORNIA, 92130
Covered Properties
(26)
Mutilin Derivatives and Their Use as Antibacterials
Patent:
6,784,193 →
Application:
10/048,438 →
Pleuromutilin Derivatives Having Antibacterial Activity
Antibacterial Mutilins
Use of Pleuromutilins for the Treatment of Disorders Caused by Helicobacter Pylori
Pleuromutilin Derivatives as Antimicrobials
Mutilin Derivatives and Their Use as Antibacterials
Antibacterial Mutilins
Pleuromutilin Derivatives Containing a Hydroxyamino- or Acyloxyaminocycloalkyl Group
Organic Compounds
Tuberculosis Treatment Using Pleuromutilin Derivatives
Organic Compounds
Process for the Preparation of Pleuromutilins
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Organic Compounds
Pleuromutilin Derivatives and Their Use as Antimicrobials
Organic Compounds
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Substituted Clavulanic Acid
Pleuromutilins and Process for the Preparation of Pleuromutilins
Enantiomerically Pure Amines
Process for the Preparation of Pleuromutilins
Pleuromutilin Derivatives for Use in the Treatment of Diseases Mediated by Microbes
Method for Improving Drug Treatments in Mammals
12-Epi Pleuromutilins
Method for Improving Drug Treatments in Mammals
Injectable Pharmaceutical Formulations of Lefamulin
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0040 →
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0007 →
Assignment of Assignor's Interest
Jan 17, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018783/0780 →
Assignment of Assignor's Interest
Feb 22, 2007
From: ASCHER, GERD; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 018931/0846 →
Assignment of Assignor's Interest
Mar 1, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: BIOCHEMIE GESELLSCHAFT M.B.H.
Reel/Frame 018955/0941 →
Assignment of Assignor's Interest
Mar 20, 2007
From: ASCHER, GERD; BERNER, HEINZ; HILDEBRANDT, JOHANNES
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019046/0854 →
Assignment of Assignor's Interest
Mar 21, 2007
From: BERNER, HEINZ; KERBER, GABRIELE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019049/0959 →
Change of Name
Apr 6, 2007
From: BIOCHEMIE GESELLSCHAFT M.B.H. (AKA BIOCHEMIE GMBH)
To: SANDOZ GMBH
Reel/Frame 019132/0047 →
Assignment of Assignor's Interest
Jun 13, 2007
From: ASCHER, GERD; BERNER, HEINZ; MANG, ROSEMARIE
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 019479/0230 →
Assignment of Assignor's Interest
Nov 15, 2007
From: MANG, ROSEMARIE; ASCHER, GERD; FERENCIC, MATHIAS; HEILMAYER, WENER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0912 →
Assignment of Assignor's Interest
Nov 15, 2007
From: THIRRING, KLAUS; ASCHER, GERD; PAUKNER, SUSANNE; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020130/0910 →
Assignment of Assignor's Interest
May 12, 2008
From: MANG, ROSEMARIE; BERNER, HEINZ
To: NABRIVA THERAPEUTICS AG
Reel/Frame 020933/0554 →
Change of Name
Aug 11, 2008
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021371/0769 →
Assignment of Assignor's Interest
Aug 13, 2008
From: SANDOZ GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021380/0209 →
Assignment of Assignor's Interest
May 15, 2009
From: MACHER, INGOLF; BERGER, ANDREAS; DE CRISTOFORO, MARTIN
To: NABRIVA THERAPEUTICS AG
Reel/Frame 022691/0682 →
Assignment of Assignor's Interest
Sep 17, 2009
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023249/0229 →
Assignment of Assignor's Interest
Jan 29, 2010
From: THIRRING, KLAUS; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023873/0791 →
Assignment of Assignor's Interest
Mar 11, 2010
From: THIRRING, KLAUS; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 024069/0305 →
Assignment of Assignor's Interest
Apr 11, 2011
From: MANG, ROSEMARIE; HEILMAYER, WERNER
To: NABRIVA THERAPEUTICS AG
Reel/Frame 026105/0458 →
Assignment of Assignor's Interest
Feb 22, 2012
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 027745/0615 →
Security Interest
Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Lien
Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Lien
Sep 5, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033694/0165 →
Change of Name
Sep 24, 2014
From: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 033813/0230 →
Security Interest
Sep 26, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033833/0311 →